0001491519-20-000005.txt : 20200702 0001491519-20-000005.hdr.sgml : 20200702 20200702173239 ACCESSION NUMBER: 0001491519-20-000005 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200701 FILED AS OF DATE: 20200702 DATE AS OF CHANGE: 20200702 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Davis Chaim CENTRAL INDEX KEY: 0001491519 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-28666 FILM NUMBER: 201011047 MAIL ADDRESS: STREET 1: 2601 PINE TREE DRIVE CITY: MIAMI BEACH STATE: FL ZIP: 33140 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMERICAN BIO MEDICA CORP CENTRAL INDEX KEY: 0000896747 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141702188 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 122 SMITH ROAD CITY: KINDERHOOK STATE: NY ZIP: 12106 BUSINESS PHONE: 5187588158 MAIL ADDRESS: STREET 1: 122 SMITH ROAD CITY: KINDERHOOK STATE: NY ZIP: 12106 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2020-07-01 0 0000896747 AMERICAN BIO MEDICA CORP ABMC 0001491519 Davis Chaim 2601 PINE TREE DRIVE MIAMI BEACH FL 33140 1 0 0 0 Common Shares 2020-07-01 4 A 0 35461 0.37 A 240561 D 35,461 restricted common shares were issued to Davis in connection with his attendance at three (3) meetings of the Board of Directors. The meetings were held on April 22, 2020 (15,259 shares), May 20, 2020 (16,339 shares) and June 23, 2020 (3,863 shares). This stock issuance is in accordance with the director compensation structure approved by the Company's Board of Directors on March 22, 2018 (as indicted in the Company's Proxy Statement filed with the Commission on April 18, 2018). The Company uses the average volume weighted price (VWAP) of the Company's common shares for the 10 days preceding each meeting to determine the value of the common shares. The VWAP was $0.1884 for the meeting held on April 22, 2020, $0.176 for the meeting held on May 20, 2020 and $0.7443 for the meeting held on June 23, 2020. This results in an average VWAP of $0.37. This is the number of securities held directly by Davis. It does not include 2,978,486 common shares in the name of Revach Fund, LP (deemed to be indirectly held by Davis). Davis is the managing member of Revach Group, LLC which operates as the general partner of Revach Fund, LP. Chaim Davis 2020-07-02